Wireless home prehabilitation for older adults with NSCLC awaiting lung surgery
Official title: Home-Based Prehabilitation Using Wireless Wearable Mobile Monitoring Devices for Elderly Patients With Non-Small Cell Lung Cancer
Run by West China Hospital · NCT07809763 · Data updated 2026-11-12
This study tests whether a personalized home exercise program guided by wearable devices can improve lung function for older NSCLC patients preparing for curative lung surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years to 85 Years |
| Sex | All |
| Enrollment | 196 (estimated) |
| Sponsor | West China Hospital Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Status | Recruiting |
| Started | September 10, 2026 |
| Main results expected | July 31, 2028 |
| Study ends | July 31, 2028 |
| Registry record updated | September 9, 2026 |
| Trial ID | NCT07809763 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 65–85 with NSCLC scheduled for elective curative lobectomy or segmentectomy, able to use a smartphone app and wearable devices, and with suitable ECOG/KPS status.
✕Probably not a fit
Patients who cannot engage with home monitoring tech, have unstable comorbidities, or do not complete the prehabilitation program may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this randomized trial, patients aged 65–85 with NSCLC scheduled for curative lobectomy or segmentectomy receive a home-based prehabilitation program or standard perioperative care. The intervention uses wireless wearables and a smartphone app to monitor steps, heart rate, and oxygen saturation while delivering a tailored mix of aerobic, resistance, and inspiratory muscle exercises for 2–4 weeks before surgery and through 90 days after. Primary outcome is the difference in FEV1 percent predicted at 90 days post-surgery, adjusted for baseline, with several secondary endpoints including functional capacity, daily activity, hypoxemia measures, patient-reported quality of life, dyspnea, postoperative complications, and readmissions. The trial aims to determine safety and feasibility as well as potential improvements in recovery. Enrollment is restricted to older adults with adequate access to and ability to use the monitoring devices and app, under the care of West China Hospital in Chengdu, China.
Why it matters
Potential benefit: If successful, patients may experience better lung function and recovery after surgery, with potential reductions in complications and hospital readmissions.
How similar studies have gone: Previous studies in rehabilitation and perioperative optimization have shown trends toward improved function with home-based programs, but this exact wearable-guided prehabilitation approach is relatively novel in this population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥65 and ≤85 years * Histopathologically confirmed primary non-small cell lung cancer (NSCLC), scheduled for elective curative-intent lobectomy or segmentectomy * Eastern Cooperative Oncology Group (ECOG) performance status 0-2, or Karnofsky Performance Status (KPS) score ≥70 * Planned admission for surgery within 2 months, and judged by the investigator to have stable disease suitable for participation in a home-based rehabilitation program * Able to operate a smartphone application and wearable devices independently or with caregiver assistance * Willing and able to provide written informed consent Exclusion Criteria: * Pre-existing long-term home oxygen therapy, or severe resting respiratory dysfunction * Concurrent severe, uncontrolled cardiovascular disease, hepatic insufficiency, or renal insufficiency * Other diseases that seriously affect motor function or compliance * Known or suspected contact allergy to medical adhesives or materials used in the wearable devices * Any other condition that, in the investigator's judgment, makes the subject unsuitable for participation
Where it's running
-
West China Hospital
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Xuelei Ma, MD
- Email: linnan@stu.scu.edu.cn
- Phone: 18708305692
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Integrated wearable-based perioperative care for NSCLC patients undergoing thoracic surgery
This study tests whether a wearable-enabled digital perioperative rehab program improves recovery for adults with NSCLC having thoracic surgery compared with standard care.
-
CR-002 study in adults with advanced solid tumors
This trial tests CR-002 as a single therapy to see if it is safe and tolerable in adults with locally advanced or metastatic solid tumors
-
NSCLC biomarker study using tumor and blood samples to link genetics with prognosis and immunotherapy response
Researchers will test tumor tissue and blood from about 300 NSCLC patients to find genomic and immune markers that predict prognosis and response to immunotherapy.
-
Preoperative functional optimization for adults undergoing major cardiac or abdominal surgery
This study tests a four‑week prehabilitation program to improve fitness before elective major cardiac or abdominal surgery.
-
Multimodal Prehabilitation for Gastric Cancer Patients
This program tests whether a combined pre- and post-operative wellness plan can reduce inflammation after gastric cancer surgery in adults.
-
AirGo Respiratory Monitoring During Lung Resection
Patients undergoing lung resection will wear the AirGo device to continuously monitor breathing before and after surgery to see if it helps track ventilation alongside standard checks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.